{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:55:34Z","timestamp":1784613334345,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1208\/s12249-019-1431-y","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T22:20:14Z","timestamp":1559600414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Designing of a pH-Triggered Carbopol\u00ae\/HPMC In Situ Gel for Ocular Delivery of Dorzolamide HCl: In Vitro, In Vivo, and Ex Vivo Evaluation"],"prefix":"10.1208","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1399-7335","authenticated-orcid":false,"given":"Maryam","family":"Kouchak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Mahmoodzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereydoun","family":"Farrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,3]]},"reference":[{"issue":"5","key":"1431_CR1","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1136\/bjo.86.5.551","volume":"86","author":"DN Bateman","year":"2002","unstructured":"Bateman DN, Clark R, Azuara-Blanco A, Bain M, Forrest J. The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophtalmological health care. Br J Ophtalmol. 2002;86(5):551\u20134.","journal-title":"Br J Ophtalmol"},{"key":"1431_CR2","first-page":"3193","volume-title":"Drug facts and comparisons","author":"EK Kastrup","year":"2012","unstructured":"Kastrup EK. Drug facts and comparisons. USA: Wolters Kluwer Health; 2012. p. 3193\u20134."},{"issue":"10","key":"1431_CR3","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s00417-010-1383-0","volume":"248","author":"IP Kaur","year":"2010","unstructured":"Kaur IP, Aggarwal D, Singh H, Kakkar S. Improved ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal delivery system. Graefes Arch Clin Exp Ophthalmol. 2010;248(10):1467\u201372.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"1431_CR4","doi-asserted-by":"publisher","first-page":"e20126","DOI":"10.17795\/jjnpp-20126","volume":"9","author":"M Kouchak","year":"2014","unstructured":"Kouchak M. In situ gelling systems for drug delivery. Jundishapur J Nat Pharm Prod. 2014;9(3):e20126.","journal-title":"Jundishapur J Nat Pharm Prod"},{"key":"1431_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0168-3659(00)00329-1","volume":"69","author":"H Lin","year":"2000","unstructured":"Lin H, Sung KC. Carbopol\u00ae\/pluronic phase change solutions for ophthalmic drug delivery. J Control Release. 2000;69:379\u201388.","journal-title":"J Control Release"},{"issue":"2\u20133","key":"1431_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0168-3659(01)00279-6","volume":"73","author":"B Srividya","year":"2001","unstructured":"Srividya B, Cardoza RM, Amin PD. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Release. 2001;73(2\u20133):205\u201311.","journal-title":"J Control Release"},{"issue":"4","key":"1431_CR7","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3797\/scipharm.1001-06","volume":"78","author":"S Gupta","year":"2010","unstructured":"Gupta S, Vyas SP. Carbopol\/chitosan based pH triggered in situ gelling system for ocular delivery of timolol maleate. Sci Pharm. 2010;78(4):959\u201376.","journal-title":"Sci Pharm"},{"key":"1431_CR8","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.addr.2006.09.020","volume":"58","author":"D Schmaljohann","year":"2006","unstructured":"Schmaljohann D. Thermo- and pH-responsive polymers in drug delivery. Adv Drug Deliv Rev. 2006;58:1655\u201370.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"1431_CR9","first-page":"60","volume":"3","author":"H Dol","year":"2014","unstructured":"Dol H, Gandhi S, Pardhi D, Vyawahare N. Formulation and evaluation of in situ ophthalmic gel of moxifloxacin hydrochloride. Pharma Innov. 2014;3(5):60\u20138.","journal-title":"Pharma Innov"},{"key":"1431_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ijpharm.2006.12.038","volume":"337","author":"H Qi","year":"2007","unstructured":"Qi H, Chen W, Hung CH, Li L, Chen CH, Li W, et al. Development of a poloxamer analogs\/carbapol\u00ae-based in situ gelling and mucoadhesive ophthalmic delivery system for purain. Int J Pharm. 2007;337:178\u201387.","journal-title":"Int J Pharm"},{"key":"1431_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2174\/1874126600802010061","volume":"2","author":"J Varshosaz","year":"2008","unstructured":"Varshosaz J, Tabbakian M, Salmani Z. Designing of a thermosensitive chitosan\/poloxamer in situ gel for ocular delivery of ciprofloxacin. Open Drug Deliv J. 2008;2:61\u201370.","journal-title":"Open Drug Deliv J"},{"issue":"2","key":"1431_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4103\/0975-7406.111824","volume":"5","author":"H Gupta","year":"2013","unstructured":"Gupta H, Aqil M, Khar RK, Bhatnagar A, Mittal G. Nanoparticles laden in situ gel for sustained ocular drug delivery. J Pharm Bioallied Sci. 2013;5(2):162\u201372.","journal-title":"J Pharm Bioallied Sci"},{"issue":"5","key":"1431_CR13","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3109\/03639045.2012.707203","volume":"39","author":"MK Pathak","year":"2013","unstructured":"Pathak MK, Chhabra G, Pathak K. Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: ex-vivo transcorneal permeation, corneal toxicity and irritation testing. Drug Dev Ind Pharm. 2013;39(5):780\u201390.","journal-title":"Drug Dev Ind Pharm"},{"key":"1431_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijpharm.2011.03.042","volume":"411","author":"D Ilva","year":"2011","unstructured":"Ilva D, Colin R, Raid G. Comparison of ion-activated in situ gelling system for ocular drug delivery. Part 1: physicochemical characterization and in vitro release. Int J Pharm. 2011;411:69\u201377.","journal-title":"Int J Pharm"},{"key":"1431_CR15","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.ijbiomac.2014.10.014","volume":"72","author":"YS Chhonker","year":"2015","unstructured":"Chhonker YS, Prasad YD, Chandasana H, Vishvkarma A, Mitra K, Shukla PK, et al. Amphotericin-B entrapped lecithin\/chitosan nanoparticles for prolonged ocular application. Int J Biol Macromol. 2015;72:1451\u20138.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"1431_CR16","first-page":"205","volume":"15","author":"M Kouchak","year":"2016","unstructured":"Kouchak M, Bahmandar R, Bavarsad N. Ocular dorzolamide nanoliposomes for prolonged IOP reduction: in-vitro and in-vivo evaluation in rabbits. Iran J Pharm Res. 2016;15(1):205\u201312.","journal-title":"Iran J Pharm Res"},{"issue":"1","key":"1431_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ijpharm.2014.10.035","volume":"477","author":"H Chandasana","year":"2014","unstructured":"Chandasana H, Prasad YD, Chhonker YS, Chaitanya TK, Mishra NN, Mitra K, et al. Corneal targeted nanoparticles for sustained natamycin delivery and their PK\/PD indices: an approach to reduce dose and dosing frequency. Int J Pharm. 2014;477(1):317\u201325.","journal-title":"Int J Pharm"},{"issue":"2","key":"1431_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","volume":"13","author":"CP Sousa","year":"2001","unstructured":"Sousa CP, Lobo JM. Modelling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123\u201333.","journal-title":"Eur J Pharm Sci"},{"key":"1431_CR19","doi-asserted-by":"crossref","unstructured":"Kassaye L, Geneta G. Evalution and comparison of in-vitro dissolution profiles for different brands of amoxicillin capsules. Afr Health Sci. 2013;(2):375\u201396.","DOI":"10.4314\/ahs.v13i2.25"},{"issue":"3","key":"1431_CR20","first-page":"942","volume":"6","author":"A Dubey","year":"2014","unstructured":"Dubey A, Prabhu P. Development and investigation of niosomes of brimonidine tartrate and timolol maleate for the treatment of glaucoma. Development. 2014;6(3):942\u201350.","journal-title":"Development."},{"key":"1431_CR21","first-page":"68","volume":"166","author":"H Ping","year":"1998","unstructured":"Ping H, Stanley S, Davis L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm. 1998;166:68\u201375.","journal-title":"Int J Pharm"},{"key":"1431_CR22","volume-title":"Martin\u2019s physical pharmacy and pharmaceutical sciences","author":"PJ Sinko","year":"2011","unstructured":"Sinko PJ. Martin\u2019s physical pharmacy and pharmaceutical sciences. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2011.","edition":"6"},{"issue":"11","key":"1431_CR23","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3109\/03639045.2012.736515","volume":"39","author":"D Achouri","year":"2013","unstructured":"Achouri D, Alhanout K, Piccerelle P, Andrieu V. Recent advances in ocular drug delivery. Drug Dev Ind Pharm. 2013;39(11):1599\u2013617.","journal-title":"Drug Dev Ind Pharm"},{"issue":"06","key":"1431_CR24","first-page":"1","volume":"2","author":"H Almeida","year":"2012","unstructured":"Almeida H, Amaral MH, Lob\u00e3o P. Temperature and pH stimuli-responsive polymers and their applications in controlled and self-regulated drug delivery. J Appl Pharm Sci. 2012;2(06):1\u201310.","journal-title":"J Appl Pharm Sci"},{"issue":"8","key":"1431_CR25","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1080\/03639045.2017.1386196","volume":"44","author":"M Kouchak","year":"2018","unstructured":"Kouchak M, Malekahmadi M, Bavarsad N, Saki-Malehi A, Andishmand L. Dorzolamide nanoliposome as a long action ophthalmic delivery system in open angle glaucoma and ocular hypertension patients. Drug Dev Ind Pharm. 2018;44(8):1239\u201342.","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"1431_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1248\/yakushi.127.183","volume":"127","author":"C Wu","year":"2007","unstructured":"Wu C, Qi H, Chen W, Huang C, Su C, Li W. Preparation and evaluation of a Carbopol\u00ae\/HPMC in situ gelling ophthalmic system for puerarin. Yakugaku Zasshi. 2007;127(1):183\u201391.","journal-title":"Yakugaku Zasshi"},{"issue":"4","key":"1431_CR27","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.drudis.2013.10.001","volume":"19","author":"H Almeida","year":"2014","unstructured":"Almeida H, Amaral MH, Loba\u02dco P. In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations. Drug Discov Today. 2014;19(4):122\u201335.","journal-title":"Drug Discov Today"},{"issue":"9","key":"1431_CR28","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1081\/DDC-100101318","volume":"26","author":"A Singla","year":"2000","unstructured":"Singla A, Chawla M, Singh A. Potential applications of carbomer in oral mucoadhesive controlled drug delivery system. Drug Dev Ind Pharm. 2000;26(9):913\u201324.","journal-title":"Drug Dev Ind Pharm"},{"key":"1431_CR29","first-page":"24","volume":"2","author":"G Rajoria","year":"2012","unstructured":"Rajoria G, Gopala N. In-situ gelling system: a novel approach for ocular drug delivery. AJPTR. 2012;2:24\u201353.","journal-title":"AJPTR."}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1431-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-019-1431-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1431-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T23:46:37Z","timestamp":1591055197000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-019-1431-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,3]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["1431"],"URL":"https:\/\/doi.org\/10.1208\/s12249-019-1431-y","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,3]]},"assertion":[{"value":"12 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed on 15 male rabbits. The animal experiments were conducted in full compliance with the regulatory principles of ethics committee of Ahvaz Jundishapur University of Medical Sciences, and the study was approved by this committee (IR.AJUMS.REC.1396.44).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"210"}}